Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.68NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.1.121NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.121NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.121NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AA.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AA.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AA.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AS.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AS.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.115NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.115NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.115NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.127.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.127.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.127.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.88NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.88NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.168NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.168NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.168NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.39NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.57NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.57NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.57NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AH.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AH.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AH.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.289NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.289NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.289NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.365NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.365NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.365NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.252NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.252NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.252NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.223NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.223NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.223NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.640.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.640.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.640.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.11 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.11 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used